{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:34:17Z","timestamp":1761824057317},"reference-count":11,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bulcan.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T02:06:15Z","timestamp":1535681175000},"page":"839-841","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autopsie d\u2019un consensus d\u2019expert. Pour en finir avec la chimioth\u00e9rapie hyperthermique intrap\u00e9riton\u00e9ale dans la carcinose colorectale"],"prefix":"10.1016","volume":"105","author":[{"given":"Serge","family":"Evrard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bulcan.2018.07.001_bib0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jso.21053","article-title":"Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination","volume":"98","author":"Esquivel","year":"2008","journal-title":"J Surg Oncol"},{"issue":"20","key":"10.1016\/j.bulcan.2018.07.001_bib0065","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2018.07.001_bib0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.07.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","author":"Elias","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2018.07.001_bib0080","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","article-title":"Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?","volume":"13","author":"Sugarbaker","year":"2012","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2018.07.001_bib0085","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1016\/S1470-2045(12)70448-5","article-title":"HIPEC: standard of care or an experimental approach?","volume":"13","author":"Evrard","year":"2012","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.bulcan.2018.07.001_bib0090","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1200\/JCO.2009.27.7723","article-title":"Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group randomized phase III max study","volume":"28","author":"Tebbutt","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2018.07.001_bib0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.bulcan.2018.07.001_bib0100","doi-asserted-by":"crossref","first-page":"e0122816","DOI":"10.1371\/journal.pone.0122816","article-title":"Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only","volume":"10","author":"Desolneux","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bulcan.2018.07.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","article-title":"A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7","volume":"36","author":"Quenet","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.07.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.3531","article-title":"Results of a randomized phase 3\u00a0study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP \u2013\u00a0NTC01226394)","volume":"36","author":"Goere","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118302182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118302182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T12:44:45Z","timestamp":1537533885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455118302182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0007455118302182"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.07.001","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autopsie d\u2019un consensus d\u2019expert. Pour en finir avec la chimioth\u00e9rapie hyperthermique intrap\u00e9riton\u00e9ale dans la carcinose colorectale","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}